Nicotine inhaler substantially improves smoking cessation treatment Many smokers will tell you that giving up cigarettes is not easy. That said, a recent study published in Nicotine & Tobacco Research ...

Please provide your email address to receive an email when new articles are posted on . There is a current lack of new, approved smoking cessation therapies. The RespiRx Nicotine Inhaler may address ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.

RICHMOND, Va., Jan. 7, 2025 /PRNewswire/ -- Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery ...

July 25 (Reuters) - A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's (AZN.L), opens new tab inhaler for the treatment of a chronic lung ...

- Funds will advance RespiRx ™ Nicotine Inhaler to Marketing Authorization Application (MAA) submission and accelerate the path to commercialization in the UK - RICHMOND, Va., Dec. 10, 2024 ...

Smoking isn’t cool anymore! According to Gallup polling, in the mid-1950s, approximately 45% of the adult population in the U ...